Saltar ao contenido
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Idioma
Todos os campos
Title
Autor
Subject
Número de Clasificación
ISBN/ISSN
Tag
Buscar
Avanzado
Discordance between power Dopp...
Citar
Text this
Enviar este rexistro por email
Imprimir
Exportar rexistro
Exportar a RefWorks
Exportar a EndNoteWeb
Exportar a EndNote
Permanent link
Discordance between power Doppler and DAS28 assessment of remission induction in a randomised, placebo-controlled stud of infliximab therapy in early rheumatoid arthritis
Detalles Bibliográficos
Main Authors:
Taylor, P
,
Steuer, A
,
McClinton, C
,
Blomley, M
,
Wagner, C
,
Marsters, P
,
Maini, R
Formato:
Conference item
Publicado:
2005
Existencias
Descripción
Títulos similares
Staff View
Títulos similares
Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritis.
por: Taylor, P, et al.
Publicado: (2004)
Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiological evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritis.
por: Taylor, P, et al.
Publicado: (2003)
Comparison of remission induction in erosive early KA assessed by DAS28 calculated using either ESR or CRP in infliximab plus MTX combination therapy or MTX monotherapy
por: Taylor, P, et al.
Publicado: (2005)
Kinetics of change in erosion scores as assessed by plain radiography and high frequency ultrasound in a randomised, controlled trial of infliximab plus MTX versus MTX only therapy in erosive early rheumatoid arthritis
por: Taylor, P, et al.
Publicado: (2005)
Comparison of ultrasonographic measures of synovitis and radiographic assessment of structural damage over two years in a randomised, controlled trial of infliximab therapy in erosive early rheumatoid arthritis.
por: Taylor, P, et al.
Publicado: (2004)